Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial.
Zhitao YingDehui ZouHaiyan YangJianqiu WuYe GuoWenyu LiHui LiuChris WangLaura MaSu YangZisong ZhouYun QinYu-Qin SongJun ZhuPublished in: American journal of hematology (2022)